These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8690899)

  • 21. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation.
    Muraille E; De Smedt T; Thielemans K; Urbain J; Moser M; Leo O
    Cell Immunol; 1995 May; 162(2):315-20. PubMed ID: 7538050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ; Lozano M; Binhazim AA; Dudley JP
    J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superantigens of mouse mammary tumor virus.
    Acha-Orbea H; MacDonald HR
    Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.
    Tan JT; Whitmire JK; Ahmed R; Pearson TC; Larsen CP
    J Immunol; 1999 Nov; 163(9):4859-68. PubMed ID: 10528187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice.
    Papiernik M; Pontoux C; Golstein P
    Eur J Immunol; 1995 Jun; 25(6):1517-23. PubMed ID: 7542196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival.
    Yin D; Zhang L; Wang R; Radvanyi L; Haudenschild C; Fang Q; Kehry MR; Shi Y
    J Immunol; 1999 Oct; 163(8):4328-34. PubMed ID: 10510372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E; Verolin M; Stensson A; Lycke N
    Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coevolutive mechanisms between retroviruses and their hosts. The murine mammary tumor model].
    Nepomnaschy I; Buggiano V; Goldman A; Piazzon I
    Medicina (B Aires); 1997; 57(2):235-44. PubMed ID: 9532836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
    Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
    J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Superantigens and murine mammary tumor retrovirus].
    Piazzon I; Nepomnaschy I; Buggiano V; Bekinschtein P; Goldman A; Berguer P; Deroche A; Lombardi G
    Medicina (B Aires); 1997; 57 Suppl 2():21-33. PubMed ID: 9567341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen.
    Modlin CS; Muruve NA; Stanko D; Caulfield MJ; Fairchild RL
    Cell Immunol; 1996 May; 169(2):252-63. PubMed ID: 8620553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus.
    Ando Y; Wajjwalku W; Kishihara K; Arai T; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    Immunobiology; 1996 Aug; 195(3):376-84. PubMed ID: 8877410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
    Held W; Waanders GA; MacDonald HR; Acha-Orbea H
    Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.